While GLP1 receptor agonists have long been recognized for their glucose-lowering and weight-loss effects, they now offer potential for improving liver outcomes, especially in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) or its more advanced form, metabolic dysfunction-associated steatohepatitis (MASH)
Its potential benefits make it a promising candidate for addressing gut-related conditions, including ulcers, inflammatory bowel disease (IBD), and leaky gut syndrome, by supporting the bodys natural healing processes and improving gut function
IGF-1 complements this by promoting the repair and regeneration of blood vessels, improving overall vascular health
& Wu, Z.-Y
Questions like "does Qsymia cause insomnia?", "does Qsymia cause dry mouth?", and "does Qsymia cause anxiety?" are valid concerns due to the stimulant nature of phentermine
Shimizu, M